ESLA vs. NPKI
ESLA (Estrella Immunopharma Inc.) and NPKI (NPK International Inc) are both stocks. ESLA operates in Biotechnology (Healthcare), while NPKI operates in Oil & Gas Equipment & Services (Energy). Over the past 3 years, ESLA returned -54.72%/yr vs 47.79%/yr for NPKI. At a 0.07 correlation, their price movements are largely independent.
Performance
ESLA vs. NPKI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ESLA achieves a -35.90% return, which is significantly lower than NPKI's 29.45% return.
ESLA
- 1D
- 7.05%
- 1M
- -13.79%
- YTD
- -35.90%
- 6M
- -34.21%
- 1Y
- 8.70%
- 3Y*
- -54.72%
- 5Y*
- —
- 10Y*
- —
NPKI
- 1D
- 0.72%
- 1M
- -0.58%
- YTD
- 29.45%
- 6M
- 26.27%
- 1Y
- 80.68%
- 3Y*
- 47.79%
- 5Y*
- 31.53%
- 10Y*
- 10.11%
ESLA vs. NPKI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
ESLA Estrella Immunopharma Inc. | -35.90% | 30.00% | 8.11% | -89.21% | 3.83% | 0.61% |
NPKI NPK International Inc | 29.45% | 55.41% | 15.51% | 60.00% | 41.16% | 8.49% |
Correlation
The correlation between ESLA and NPKI is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.17 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.11 |
Correlation (All Time) Calculated using the full available price history since Sep 14, 2021 | 0.07 |
The correlation between ESLA and NPKI shifts across timeframes, from 0.07 (all time) to 0.17 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
ESLA:
$42.12M
NPKI:
$1.32B
ESLA:
-$0.35
NPKI:
$0.44
ESLA:
$0.00
NPKI:
$287.34M
ESLA:
$0.00
NPKI:
$102.70M
ESLA:
-$13.25M
NPKI:
$27.55M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ESLA vs. NPKI — Risk / Return Rank
ESLA
NPKI
ESLA vs. NPKI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Estrella Immunopharma Inc. (ESLA) and NPK International Inc (NPKI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ESLA | NPKI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.17 | ||
| Sortino ratioReturn per unit of downside risk | -1.80 | ||
| Omega ratioGain probability vs. loss probability | 1.12 | 1.34 | -0.22 |
| Calmar ratioReturn relative to maximum drawdown | 0.12 | 4.52 | -4.40 |
| Martin ratioReturn relative to average drawdown | 0.20 | 13.54 | -13.35 |
Loading charts...
Drawdowns
ESLA vs. NPKI - Drawdown Comparison
The maximum ESLA drawdown since its inception was -96.58%, roughly equal to the maximum NPKI drawdown of -97.22%. Use the drawdown chart below to compare losses from any high point for ESLA and NPKI.
Loading charts...
Drawdown Indicators
| ESLA | NPKI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.58% | -97.22% | +0.64% |
Max Drawdown (1Y)Largest decline over 1 year | -70.13% | -17.94% | -52.19% |
Max Drawdown (3Y)Largest decline over 3 years | -96.58% | -42.11% | -54.47% |
Max Drawdown (5Y)Largest decline over 5 years | — | -49.37% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -94.07% | — |
Current DrawdownCurrent decline from peak | -95.29% | -35.87% | -59.42% |
Average DrawdownAverage peak-to-trough decline | -55.78% | -60.07% | +4.29% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 44.10% | 5.98% | +38.12% |
Volatility
ESLA vs. NPKI - Volatility Comparison
Estrella Immunopharma Inc. (ESLA) has a higher volatility of 18.90% compared to NPK International Inc (NPKI) at 11.79%. This indicates that ESLA's price experiences larger fluctuations and is considered to be riskier than NPKI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ESLA | NPKI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.90% | 11.79% | +7.11% |
Volatility (6M)Calculated over the trailing 6-month period | 72.06% | 27.90% | +44.16% |
Volatility (1Y)Calculated over the trailing 1-year period | 111.74% | 36.11% | +75.63% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 134.35% | 49.49% | +84.86% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 134.35% | 62.18% | +72.17% |
Dividends
ESLA vs. NPKI - Dividend Comparison
Neither ESLA nor NPKI has paid dividends to shareholders.
Financials
ESLA vs. NPKI - Financials Comparison
This section allows you to compare key financial metrics between Estrella Immunopharma Inc. and NPK International Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ESLA and NPKI have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ESLA has higher volatility (18.90%) compared to NPKI (11.79%). In terms of maximum drawdown, ESLA dropped -96.58% vs NPKI's -97.22%.
NPKI currently has the higher Sharpe Ratio (2.25 vs 0.08), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ESLA and NPKI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer